Trevor D. Schuler

Trevor D. Schuler

Auto-generated profile, based on publicly available information

Trevor D. Schuler

Department of Urology, University of Alberta, Edmonton, Alberta, Canada

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2009 in Journal of Endourology
Verified
Journal Article
Closed access
TSTrevor D. Schuler
Trevor D. Schuler
RSRohan Shahani
Rohan Shahani
RHR. John D'A. Honey
R. John D'A. Honey
KPKenneth T. Pace
Kenneth T. Pace
Modern shockwave lithotripsy (SWL) is associated with inferior results compared with the original Dornier HM3. To enhance SWL outcomes, improved patient selection based on radiographic features and modulation of shockwave delivery rate have been used. A growing body of evidence demonstrates the positive effect of medical expulsive therapy (MET) to improve spontaneous passage of urinary calculi. The purpose of this review is to tabulate the current available data that examine the addition of MET to SWL to enhance outcomes. MEDLINE was searched with a strategy developed in conjunction with a medical librarian. Trials were included if patients were randomized to receive either a medical expulsive agent or placebo or standard therapy after SWL. Study quality was assessed according to the Cochrane Renal Group criteria. The data were analyzed using RevMan meta-analysis software. Subgroup analysis was performed with respect to MET agent used, stone size, and duration of follow-up. Four randomized trials were identified. MET agents varied, with two trials using tamsulosin, one using nifedipine, and a single trial using Phyllanthus niruri extract. Two trials included patients with renal calculi, one had patients with ureteral calculi, and the fourth included patients with both ureteral and renal calculi. The pool results of the four trials included 212 patients who received MET and 206 who received placebo. The absolute risk difference of a successful outcome after SWL with the addition of MET was significantly superior to control at 17% (95% confidence interval [CI] 9%-24%); means six patients need to be treated with MET to prevent a single unsuccessful SWL of six (95% CI 4-11). The effect of MET post-SWL was even more pronounced for stones larger than 10 mm with an absolute risk difference of 26% (95% CI, 9%-43%). MET post-SWL results in a significant increase in successful treatment outcomes. Further powered, randomized studies are encouraged.

1 October 2024 in Journal of Urology
Verified
Journal Article
Open access
BCBen H. Chew
Ben H. Chew
JHJonathan D. Harper
Jonathan D. Harper
RSRoger L. Sur
Roger L. Sur
TCThomas Chi
Thomas Chi
SDShubha De
Shubha De
MSMathew D. Sorensen
Mathew D. Sorensen
This study reports on a prospective, multicenter, single-arm, clinical trial utilizing the SonoMotion (San Mateo, California) Break Wave lithotripsy (BWL) device to fragment urinary stones. Patients with a urinary stone underwent a single treatment of 30 minutes and peak negative pressure of 4.5 to 8 MPa. Subjects were contacted and outcomes assessed at 7, 14, and 35 days after treatment, with clinical follow-up and CT imaging 70 ± 14 days postprocedure. The primary objectives were to assess the safety (hematomas, complications, etc) and effectiveness of BWL (any fragmentation, residual fragments ≤4 mm or ≤2 mm, and completely stone-free rate) as assessed via noncontrast CT-kidneys, ureters, and bladder. Forty-four patients with a ureteral (43%) or renal (57%) stone were treated across 5 centers. Stone fragmentation occurred in 88% of cases; 70% had fragments ≤ 4 and 51% ≤ 2 mm, while 49% were completely stone free on CT; no serious adverse events were reported. Eighty-six percent of patients received either no analgesic medication at all (50%) or minor analgesia (36%). After determining optimal therapy settings, 36 patients were treated and the effectiveness improved exhibiting fragmentation in 92% (33/36), residual fragments ≤ 4 mm in 75% and 58% with fragments ≤ 2 mm with 58% completely stone free. Effectiveness was less in subjects with lower pole stones with 81% fragmentation, 71% having fragments ≤ 4 mm, 29% with fragments ≤ 2 mm, and 29% completely stone free; of distal ureteral stone patients, 89% were completely stone free. BWL offered safe and effective noninvasive stone therapy requiring little to no anesthesia and was carried out successfully in nonoperative environments. ClinicalTrials.gov identifier: NCT03811171.

10 June 2024 in Canadian Urological Association Journal
Verified
Journal Article
Closed access
PDF file
CBConrad Bayley
Conrad Bayley
DHDavid B. Hogarth
David B. Hogarth
RMRyan McLarty
Ryan McLarty
SDShubha De
Shubha De
TSTrevor Schuler
Trevor Schuler
Introduction: Non-contrast computed tomography (CT) is the gold-standard diagnostic test for urolithiasis. Little is published regarding which information needs to be included in the report for it to be most useful to the healthcare team for efficient triage and high-quality patient care. This study aimed to assess the quality and variability of CT scan reporting at a single Canadian tertiary academic medical center. Methods: We completed a retrospective review of 100 consecutive renal colic CT scans. Descriptive statistics were used to report the frequency with which specific elements commonly used by urologists to triage and treat patients were included in radiology reports. Results: Our sample had a mean age of 51.4±13.1 years. Stone size was universally reported for obstructing stones but was less frequently reported for non-obstructing stones (100% vs. 86.8%). A similar trend was observed for the exact stone number (100% vs. 93.4%). Non-obstructing stones were more likely than obstructing stones to be reported in one dimension (77.5% vs. 47%). Obstructing stones were reported in three dimensions 27% of the time. CT reports commonly include the presence or absence of hydronephrosis status (98%) but are less likely to include renal size (32%) and periureteral stranding (16%). Hounsfield units (HU) were reported in 3% of the reports, but skin-to-stone distance (SSD) and radiation dose were never reported. Conclusions: Reports routinely included assessments of stone size, location, and number (although not uniformly). HU, SSD, and radiation dose were rarely reported. This provides insight into opportunities for standardized reporting to optimize knowledge transfer that may result in clinical efficiency and improved quality of patient care.

10 June 2022 in Journal of Urological Surgery
Verified
Journal Article
Open access
CLCallum Lavoie
Callum Lavoie
MLMax Levine
Max Levine
TWTimothy Wollin
Timothy Wollin
TSTrevor Schuler
Trevor Schuler
SDShubha De
Shubha De